1. 1071PPhase II study of CC-486 in previously treated patients (pts) with locally advanced/metastatic nasopharyngeal cancer (NPC): Final results. (23rd October 2018) Authors: Mesia Nin, R; Bossi, P; Hansen, A; Hsieh, C; Licitra, L F; Tan, E H; Chen, P; Miller, J; Siu, L L; Haddad, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1078PGenomic profiling and matched therapy for recurrent or metastatic malignant salivary gland tumors. (23rd October 2018) Authors: Malone, E R; Jang, R; Spreafico, A; Weinreb, I; Jennings, S; Siu, L L; Hansen, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1088PAnalysis of immune and genomic landscapes of patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with pembrolizumab in the INSPIRE study. (23rd October 2018) Authors: Oliva Bernal, M; Lien, S; Wang, B X; Yang, S C; Spreafico, A; Jang, R; Elston, S; Jennings, S; Jiang, H; Haibe-Kains, B; Pugh, T; Ohashi, P; Siu, L L; Hansen, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1121TiPKEYNOTE-412: Phase III study of pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (HNSCC). (23rd October 2018) Authors: Machiels, J-P; Licitra, L; Tao, Y G; Yen, C-J; Rischin, D; Waldron, J N; Burtness, B A; Gregoire, V; Agarwala, S S; Yorio, J; Delord, J-P; Aksoy, S; Ikeda, S; Hong, R-L; Ge, J Y; Brown, H; Bidadi, B; Siu, L L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1122TiPPembrolizumab in patients with recurrent or metastatic cutaneous squamous cell carcinoma (cSCC): The phase II KEYNOTE-629 study. (23rd October 2018) Authors: Licitra, L F; Siu, L L; Cohen, E E W; Zhang, P; Gumuscu, B; Swaby, R; Harrington, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1123TiPA randomized phase II study of cisplatin plus radiotherapy versus durvalumab plus radiotherapy followed by adjuvant durvalumab versus durvalumab plus radiotherapy followed by adjuvant tremelimumab and durvalumab in intermediate risk, HPV-positive, locoregionally advanced oropharyngeal squamous cell cancer (LA-OSCC) (Canadian Cancer Trials Group HN.9). (23rd October 2018) Authors: Spreafico, A; Sultanem, K; Chen, B; Bratman, S V; Ringash, J; Louie, A V; McNiven, A; Whelan, K; Hilton, J; Yoo, J; Machiels, J-P; Licitra, L F; Oosting, S; Waldron, J N; Siu, L L; Parulekar, W R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 95PPredicting toxicity and response to pembrolizumab (P) through germline genomic HLA class I analysis. (23rd October 2018) Authors: Iafolla, M; Yang, C; Chandran, V; Pintilie, M; Hansen, A; Bedard, P; Lheureux, S; Spreafico, A; Razak, A; Ohashi, P; Hakgor, S; Giesler, A; Pugh, T; Siu, L L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies. (10th September 2018) Authors: Smoragiewicz, M; Bogaerts, J; Calvo, E; Marabelle, A; Perrone, A; Seymour, L; Shalabi, A; Siu, L L; Tabernero, J; Giaccone, G Journal: Annals of oncology Issue: Volume 29:Number 11(2018) Page Start: 2175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors. (27th March 2019) Authors: Hellmann, M D; Kim, T -W; Lee, C B; Goh, B -C; Miller, W H; Oh, D -Y; Jamal, R; Chee, C -E; Chow, L Q M; Gainor, J F; Desai, J; Solomon, B J; Das Thakur, M; Pitcher, B; Foster, P; Hernandez, G; Wongchenko, M J; Cha, E; Bang, Y -J; Siu, L L Journal: Annals of oncology Issue: Volume 30:Number 7(2019) Page Start: 1134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The European Society for Medical Oncology (ESMO) Precision Medicine Glossary. (13th November 2017) Authors: Yates, L R; Seoane, J; Le Tourneau, C; Siu, L L; Marais, R; Michiels, S; Soria, J C; Campbell, P; Normanno, N; Scarpa, A; Reis-Filho, J S; Rodon, J; Swanton, C; Andre, F Journal: Annals of oncology Issue: Volume 29:Number 1(2018) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗